15 insiders reported 131 Form 4 transactions for Royalty Pharma plc (RPRX) over the past 18 months (most recent 2026-09-24). Recent activity: Hite Christopher (EVP & Chairman, Partnering) Sell 96,073 shares, Hite Christopher (EVP & Chairman, Partnering) Sell 3,927 shares, Hite Christopher (EVP & Chairman, Partnering) Sell 100,000 shares, Hite Christopher (EVP & Chairman, Partnering) Sell 16,800 shares, Coyne Terrance P. (EVP & CFO) Sell 9,230 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Hite Christopher | EVP & Chairman, Partnering | Sell | 96,073 | $5.6M |
| 2026-09-24 | Hite Christopher | EVP & Chairman, Partnering | Sell | 3,927 | $231,403 |
| 2026-08-19 | Hite Christopher | EVP & Chairman, Partnering | Sell | 100,000 | $6.0M |
| 2026-08-19 | Hite Christopher | EVP & Chairman, Partnering | Sell | 16,800 | $0 |
| 2026-08-17 | Coyne Terrance P. | EVP & CFO | Sell | 9,230 | $540,752 |
| 2026-08-17 | Coyne Terrance P. | EVP & CFO | Sell | 1,772 | $104,799 |
| 2026-08-07 | Legorreta Pablo G. | CEO, Chairman of the Board | Buy | 65,216 | $0 |
| 2026-08-07 | Hite Christopher | EVP & Chairman, Partnering | Buy | 11,002 | $0 |
| 2026-08-07 | Coyne Terrance P. | EVP & CFO | Buy | 11,002 | $0 |
| 2026-08-07 | Urist Marshall | EVP, Research & Investments | Buy | 8,252 | $0 |
| 2026-07-02 | Hite Christopher | EVP & Chairman, Partnering | Sell | 2,554 | $145,841 |
| 2026-07-02 | Urist Marshall | EVP, Research & Investments | Sell | 9,099 | $508,454 |
| 2026-07-02 | Hite Christopher | EVP & Chairman, Partnering | Sell | 97,446 | $5.5M |
| 2026-07-02 | Hite Christopher | EVP & Chairman, Partnering | Sell | 29,400 | $1.7M |
| 2026-07-02 | Hite Christopher | EVP & Chairman, Partnering | Sell | 600 | $34,254 |
| 2026-06-30 | Bassler Bonnie L | Director | Buy | 689 | $37,482 |
| 2026-06-25 | Hite Christopher | EVP & Chairman, Partnering | Sell | 32,408 | $1.8M |
| 2026-06-25 | Hite Christopher | EVP & Chairman, Partnering | Sell | 117,592 | $6.4M |
| 2026-06-25 | Urist Marshall | EVP, Research & Investments | Sell | 9,098 | $502,028 |
| 2026-06-08 | Ho Carole | Director | Buy | 4,545 | $0 |
| 2026-06-08 | Norden Gregory | Director | Buy | 4,545 | $0 |
| 2026-06-08 | Coric Vlad | Director | Buy | 4,545 | $0 |
| 2026-06-08 | LOVE TED W | Director | Buy | 4,545 | $0 |
| 2026-06-08 | WEATHERMAN ELIZABETH H | Director | Buy | 4,545 | $0 |
| 2026-06-08 | HODGSON DAVID C | Director | Buy | 4,545 | $0 |
Source: SEC Form 4 filings · as of 2026-09-24